Susquehanna International Group, LLP Dexcom Inc Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $12.2 Million - $22.2 Million	191,400 Added 51.3%	564,500 $37.8 Million
Q2 2024 Aug 15, 2024	SELL	$110.31 - $140.45 $127 Million - $162 Million	-1,152,200 Reduced 75.54%	373,100 $42.3 Million
Q1 2024 May 07, 2024	SELL	$114.22 - $140.1 $262,706 - $322,230	-2,300 Reduced 0.15%	1,525,300 $212 Million
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $49.1 Million - $80.8 Million	650,400 Added 74.15%	1,527,600 $190 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $19.2 Million - $30.8 Million	223,200 Added 34.13%	877,200 $81.8 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $9.84 Million - $11.5 Million	87,500 Added 15.45%	654,000 $84 Million
Q1 2023 May 16, 2023	SELL	$104.0 - $122.92 $41.3 Million - $48.9 Million	-397,500 Reduced 41.23%	566,500 $65.8 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $44.9 Million - $64.8 Million	528,100 Added 121.15%	964,000 $109 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $2.88 Million - $3.55 Million	37,700 Added 9.47%	435,900 $35.1 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.